ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Human Factors Analysis in VR for Burn Treatment

This study is not yet open for participant recruitment.
Verified by National Institute on Drug Abuse (NIDA), April 2008

Sponsored by: National Institute on Drug Abuse (NIDA)
Information provided by: National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier: NCT00409552
  Purpose

A number of studies have shown that virtual reality (VR) can be used to distract patients from pain and anxiety during painful medical procedures for which medication provides inadequate relief. An inexpensive, commercially available VE could have significant impact in reducing perceived pain involved in a variety of medical procedures. The Virtual Reality Medical Center (VRMC) developed an engaging virtual world that proved to be effective in reducing reported pain ratings of participants experiencing several different forms of painful stimuli. The virtual world called Icy Cool World was found to successfully distract patients from painful stimuli and reduce patients' perceived levels of pain. Phase II looks to expand on these findings and examine the effectiveness as a pain distraction technique for a variety of acute and chronic pain etiologies. The main objective of the clinical investigation will be to expand on the findings from earlier studies and obtain a more comprehensive analysis regarding the clinical versatility of VR pain distraction.


Condition Intervention Phase
Pain
Chronic Pain
Behavioral: Virtual Reality based distraction
Behavioral: VR with flat projection display
Behavioral: non-interactive video with head display
Behavioral: non-interactive video with with flat projection display
Phase I
Phase II

MedlinePlus related topics:   Burns   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Supportive Care, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:   Phase 1 and 2 Study of Human Factors Analysis in VR for Burn Treatment

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Pain rating reduction [ Time Frame: Following each trial ] [ Designated as safety issue: No ]

Estimated Enrollment:   500
Study Start Date:   December 2008
Estimated Primary Completion Date:   December 2009 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
1: Experimental
Virtual Reality with head display
Behavioral: Virtual Reality based distraction
Participants will undergo virtual reality based distraction using the head display while they go through the pain process.
2: Active Comparator
Virtual Reality with flat projection display
Behavioral: VR with flat projection display
VR with flat projection display
3: Active Comparator
non-interactive video with head display
Behavioral: non-interactive video with head display
non-interactive video with head display
4: Active Comparator
non-interactive video with flat projection display
Behavioral: non-interactive video with with flat projection display
non-interactive video with with flat projection display
5: No Intervention
No distraction

  Eligibility
Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Age 18-65, male or female, any ethnicity as long as candidates can understand and read English adequately.

Exclusion Criteria:

  • We will exclude participants who meet DSM-IV-TR criteria for alcohol or other substance abuse in the past year, or are currently using any recreational drugs, or taking more than 20 alcoholic drinks a week. In addition, the Beck Depression Inventory II (BDI-II) score must be less than 16, with no suicidal ideation.
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00409552

Contacts
Contact: Mark D. Wiederhold, MD, PhD, MBA     (858)642-0267     mwiederhold@vrphobia.com    

Sponsors and Collaborators

Investigators
Principal Investigator:     Mark D Wiederhold, MD, PhD, FACP     VRMC    
  More Information


Responsible Party:   The Virtual Reality Medical Center ( Mark D. Wiederhold )
Study ID Numbers:   N44DA-5-7744
First Received:   December 8, 2006
Last Updated:   April 9, 2008
ClinicalTrials.gov Identifier:   NCT00409552
Health Authority:   United States: Federal Government

Study placed in the following topic categories:
Burns
Pain

ClinicalTrials.gov processed this record on October 22, 2008




Links to all studies - primarily for crawlers